Governments, Donors Should Invest In Vaccine Development Despite Economic Risks

Nature: Share the risks of Ebola vaccine development
Seth Berkley, chief executive of Gavi, the Vaccine Alliance

“…Vaccine development is driven not by the risk that a pathogen poses to people, but by the economic pay-off. … That helps to explain why, more than a year on from the first confirmed cases of the ongoing Ebola outbreak in West Africa, no vaccine is available, even though work started towards one more than a decade ago. … Governments and donors need to invest in public health capability, and they need to take on more of the risk of investing in vaccine development. We must view vaccines as the ultimate deterrent: make sure they are there, and pray that we never have to use them” (3/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.